The phase-three trial was carried out mostly on participants at high risk of progression to severe Covid-19, AstraZeneca added in a statement and its Evusheld jab provided protection against severe Covid-19 or death
source https://www.livemint.com/news/india/astrazeneca-claims-its-evusheld-jab-protects-against-severe-covid-19-or-death-11654712556902.html
0 Comments
Don't post spam messages